Invention Grant
- Patent Title: Deuterium-enriched pioglitazone
- Patent Title (中): 氘富集吡格列酮
-
Application No.: US12233751Application Date: 2008-09-19
-
Publication No.: US08722710B2Publication Date: 2014-05-13
- Inventor: Anthony W Czarnik
- Applicant: Anthony W Czarnik
- Applicant Address: US MA Andover
- Assignee: DeuteRx, LLC
- Current Assignee: DeuteRx, LLC
- Current Assignee Address: US MA Andover
- Agency: Goodwin Procter LLP
- Main IPC: A61K31/4436
- IPC: A61K31/4436 ; C07D417/12
Abstract:
The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
Public/Granted literature
- US20090082405A1 DEUTERIUM-ENRICHED PIOGLITAZONE Public/Granted day:2009-03-26
Information query
IPC分类:
